InvestorsHub Logo
Followers 3
Posts 607
Boards Moderated 0
Alias Born 06/07/2010

Re: Paulieme post# 228

Monday, 10/21/2013 4:15:37 PM

Monday, October 21, 2013 4:15:37 PM

Post# of 1060
Saturday, October 19, 2013
Pacific Biosciences has been squeezing 454 in applications requiring long reads. My second (of two) 454 experiments was in de novo bacterial genome assembly, and some gain over pure Illumina was had -- but just after I got that dataset I got my first PacBio dataset with HGAP correction, and it was game over for any other current platform in that application. (A good article). http://omicsomics.blogspot.com/2013/10/ripples-from-454s-shutdown-announcment.html
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent PACB News